AcebrophyllineASMASAFE 200 TABLET

Acebrophylline is a sustained-release formulation indicated for the management of chronic respiratory conditions such as bronchial asthma and chronic obstructive pulmonary disease (COPD). It offers dual-action relief through bronchodilation and mucoregulation, making it ideal for patients suffering from productive cough, breathlessness,
and airway inflammation. The sustained-release profile ensures a steady therapeutic effect over 12–24 hours, improving symptom control and patient compliance with once-daily dosing.

• Dosage: Once Daily OR as directed by the Physician.
• Form: Tablet
• Indications:
  1. Chronic Obstructive Pulmonary Disease (COPD)
  2. Bronchial asthma
  3. Chronic bronchitis
  4. Bronchiectasis
  5. Emphysema
• Composition: Acebrophylline 200 mg SR
• Mode of Action: Acebrophylline is a dual-action agent combining ambroxol and theophylline-7 acetic acid for mucolytic, bronchodilatory, and anti-inflammatory effects. It thins mucus, clears airways,
  relaxes bronchial muscles, and reduces inflammation. The sustained-release formulation ensures prolonged relief and improved patient compliance in obstructive airway disorders.
• Packaging:1*10’s
• Therapy Area: Respiratory Medicine